Where is the biggest opportunity in preventative health: general wellness or specialized clinical testing and therapies?

Klaus Hommels · published Nov 27, 2024 · hedged

Longitudinal preventative health screening has a very large market — far larger than most people assume

His own experience at the Lanserhof clinic showed him the value of tracking parameters over intervals with clear explanations of cause and effect, and people are becoming more health sensitive

Scope: framed as an implicit, subconsciously trained intuition rather than analysis

45:18 20VC: Why Price Sensitivity is BS | Why "Portfolios" are Merely a Construct to Make LPs Happy | Why the Best Investment Never Happen in "Fundraising Rounds" | What Europe Needs to do to Become a Superpower Again | Klaus Hommels, Lakestar

David George · published Dec 15, 2025

Proactive personal health management will become a large, investable consumer category over the next ten years

It's one of the large consumer categories that hasn't hit yet, and the technology capabilities to support it will be there shortly

Scope: early today; the extreme version — AI coaching narrating the life-cost tradeoff of every decision — is too much; a more positive version is what will work

61:51 20VC: a16z's David George on How $BN Funds Can 5×, Do Margins & Revenue Matter in AI & the Most Controversial Bet at a16z

Matteo Franceschetti · published Nov 20, 2023

The bed will become the most powerful preventative health platform and will save people's lives

88:13 20VC: The Ultimate Hiring Playbook: Five Questions to Ask Every New Hire | What Makes Truly Great Leaders and How They Give Feedback | Do VCs Really Add Value; Lessons from Hard Fundraises with Matteo Franceschetti, Co-Founder @ Eight Sleep

Matteo Franceschetti · published Sep 12, 2026

The bed will become the most advanced medical platform a person owns

They already detect likelihood of diabetes and hypertension in their data and are becoming a medical device for sleep apnea

31:13 20VC: 7 Predictions for How AI Changes the World: Labour, Engineering, Social Media, GrokBots Buying Cybercabs and more with Matteo Franceschetti, Co-Founder @ Eight Sleep

Andrew Dudum · published Apr 4, 2026

The most interesting opportunity in preventative health right now is highly specialized testing and therapies for large unmet clinical areas like cardiovascular disease, not general wellness

Statins cost cents to manufacture and dramatically cut heart attack risk yet almost nobody takes them; biotech therapies delivering a single quarterly or annual injection could obliterate cardiovascular risk and bend the death rate

20:43 Specialized testing and therapies for major disease burden

Paul Graham · published Mar 2012 · hedged

People 50 to 100 years from now will regard it as barbaric that we waited for symptoms before diagnosing conditions like heart disease and cancer; ongoing quantitative monitoring will be normal.

Even Bill Clinton, with the best medical care available, only learned his arteries were over 90% blocked once he felt short of breath; such numbers should be as familiar as our weight, and cancer should show up immediately on some sort of radar screen.

source Continuous quantitative health monitoring will replace symptom based diagnosis within decades

Paul Graham · published Mar 2012 · speculative

What continuous scanning detects may not match today's concept of cancer; people may have many harmless microcancers at any given time.

source Continuous scanning will reveal many harmless microcancers that dont match todays cancer concept

Paul Graham · published Mar 2012

Many doctors object that scanning asymptomatic people amounts to a fishing expedition producing incidental findings and a flood of false alarms requiring expensive, possibly dangerous follow-up tests.

Incidental discoveries are a nuisance that panic patients, as when a study scan found what looked like a large tumor but turned out to be a harmless cyst.

source Scanning asymptomatic people produces costly false alarms and incidental findings doctors object

Paul Graham · published Mar 2012

Ongoing diagnosis will happen and will be a great advance, comparable in significance to anaesthesia and antibiotics, and there is room for many startups in it.

Despite technical, bureaucratic, and traditional obstacles, the benefit is so large that future generations will pity us as we pity those who lived before anaesthesia and antibiotics.

source Ongoing diagnosis via continuous monitoring will be a major advance with room for many startups